BIOGEN INC. Stock-Based Compensation
BIOGEN INC. (BIIB) reported Stock-Based Compensation of $84.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-04-29
- BIOGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $84.00M, a 3.70% increase year-over-year.
- BIOGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $59.60M, a 20.64% decline year-over-year.
- BIOGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $75.30M, a 3.58% increase year-over-year.
- BIOGEN INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $74.90M, a 6.09% increase year-over-year.
- BIOGEN INC. share-based payment arrangement, noncash expense for fiscal 2025 was $290.80M, a 0.14% decline from fiscal 2024.
- BIOGEN INC. share-based payment arrangement, noncash expense for fiscal 2024 was $291.20M, a 10.22% increase from fiscal 2023.
- BIOGEN INC. share-based payment arrangement, noncash expense for fiscal 2023 was $264.20M, a 3.97% increase from fiscal 2022.
- BIOGEN INC. share-based payment arrangement, noncash expense for fiscal 2022 was $254.10M, a 6.50% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $84.00M 10-Q · filed 2026-04-29 | $143.60M derived: sum of 2 quarters · filed 2026-04-29 | $218.90M derived: sum of 3 quarters · filed 2026-04-29 | $293.80M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $59.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $134.90M derived: sum of 2 quarters · filed 2026-02-06 | $209.80M derived: sum of 3 quarters · filed 2026-02-06 | $290.80M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $75.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $150.20M derived: sum of 2 quarters · filed 2025-10-30 | $231.20M 10-Q · filed 2025-10-30 | $306.30M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $74.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $155.90M 10-Q · filed 2025-07-31 | $231.00M derived: sum of 3 quarters · filed 2026-04-29 | $303.70M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $81.00M 10-Q · filed 2026-04-29 | $156.10M derived: sum of 2 quarters · filed 2026-04-29 | $228.80M derived: sum of 3 quarters · filed 2026-04-29 | $299.40M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $75.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $147.80M derived: sum of 2 quarters · filed 2026-02-06 | $218.40M derived: sum of 3 quarters · filed 2026-02-06 | $291.20M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $72.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $143.30M derived: sum of 2 quarters · filed 2025-10-30 | $216.10M 10-Q · filed 2025-10-30 | $271.00M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $70.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $143.40M 10-Q · filed 2025-07-31 | $198.30M derived: sum of 3 quarters · filed 2026-02-06 | $260.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $72.80M 10-Q · filed 2025-05-01 | $127.70M derived: sum of 2 quarters · filed 2026-02-06 | $189.90M derived: sum of 3 quarters · filed 2026-02-06 | $261.40M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $54.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $117.10M derived: sum of 2 quarters · filed 2026-02-06 | $188.60M derived: sum of 3 quarters · filed 2026-02-06 | $264.20M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $62.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $133.70M derived: sum of 2 quarters · filed 2024-10-30 | $209.30M 10-Q · filed 2024-10-30 | $276.50M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $71.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $147.10M 10-Q · filed 2024-08-01 | $214.30M derived: sum of 3 quarters · filed 2025-02-12 | $277.90M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $75.60M 10-Q · filed 2024-04-24 | $142.80M derived: sum of 2 quarters · filed 2025-02-12 | $206.40M derived: sum of 3 quarters · filed 2025-02-12 | $262.10M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $67.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $130.80M derived: sum of 2 quarters · filed 2025-02-12 | $186.50M derived: sum of 3 quarters · filed 2025-02-12 | $254.10M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $63.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $119.30M derived: sum of 2 quarters · filed 2023-11-08 | $186.90M 10-Q · filed 2023-11-08 | $245.70M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $55.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $123.30M 10-Q · filed 2023-07-25 | $182.10M derived: sum of 3 quarters · filed 2024-02-14 | $237.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $67.60M 10-Q · filed 2023-04-25 | $126.40M derived: sum of 2 quarters · filed 2024-02-14 | $182.10M derived: sum of 3 quarters · filed 2024-02-14 | $236.20M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $58.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $114.50M derived: sum of 2 quarters · filed 2024-02-14 | $168.60M derived: sum of 3 quarters · filed 2024-02-14 | $238.60M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $55.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $109.80M derived: sum of 2 quarters · filed 2022-10-25 | $179.80M 10-Q · filed 2022-10-25 | $228.80M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $54.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $124.10M 10-Q · filed 2022-07-20 | $173.10M derived: sum of 3 quarters · filed 2023-02-15 | $206.60M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $70.00M 10-Q · filed 2022-05-03 | $119.00M derived: sum of 2 quarters · filed 2023-02-15 | $152.50M derived: sum of 3 quarters · filed 2023-02-15 | $200.60M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $82.50M derived: sum of 2 quarters · filed 2023-02-15 | $130.60M derived: sum of 3 quarters · filed 2023-02-15 | $198.30M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $33.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $81.60M derived: sum of 2 quarters · filed 2021-10-20 | $149.30M 10-Q · filed 2021-10-20 | $187.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $48.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $115.80M 10-Q · filed 2021-07-22 | $154.20M derived: sum of 3 quarters · filed 2022-02-03 | $200.10M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $67.70M 10-Q · filed 2021-04-22 | $106.10M derived: sum of 2 quarters · filed 2022-02-03 | $152.00M derived: sum of 3 quarters · filed 2022-02-03 | $204.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $38.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $84.30M derived: sum of 2 quarters · filed 2022-02-03 | $136.60M derived: sum of 3 quarters · filed 2022-02-03 | $182.30M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $45.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $98.20M derived: sum of 2 quarters · filed 2020-10-21 | $143.90M 10-Q · filed 2020-10-21 | $182.40M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $52.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $98.00M 10-Q · filed 2020-07-22 | $136.50M derived: sum of 3 quarters · filed 2021-02-03 | $173.80M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $45.70M 10-Q · filed 2020-04-23 | $84.20M derived: sum of 2 quarters · filed 2021-02-03 | $121.50M derived: sum of 3 quarters · filed 2021-02-03 | $159.80M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $38.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $75.80M derived: sum of 2 quarters · filed 2021-02-03 | $114.10M derived: sum of 3 quarters · filed 2021-02-03 | $157.50M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $37.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $75.60M derived: sum of 2 quarters · filed 2019-10-22 | $119.00M 10-Q · filed 2019-10-22 | $149.60M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $38.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $81.70M 10-Q · filed 2019-07-24 | $112.30M derived: sum of 3 quarters · filed 2020-02-06 | $142.40M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $43.40M 10-Q · filed 2019-04-24 | $74.00M derived: sum of 2 quarters · filed 2020-02-06 | $104.10M derived: sum of 3 quarters · filed 2020-02-06 | $134.40M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $30.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $60.70M derived: sum of 2 quarters · filed 2020-02-06 | $91.00M derived: sum of 3 quarters · filed 2020-02-06 | $128.00M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $30.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $60.40M derived: sum of 2 quarters · filed 2018-10-23 | $97.40M 10-Q · filed 2018-10-23 | $134.40M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $30.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $67.30M 10-Q · filed 2018-07-24 | $104.30M derived: sum of 3 quarters · filed 2019-02-06 | $138.00M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $37.00M 10-Q · filed 2018-04-24 | $74.00M derived: sum of 2 quarters · filed 2019-02-06 | $107.70M derived: sum of 3 quarters · filed 2019-02-06 | $146.50M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $70.70M derived: sum of 2 quarters · filed 2019-02-06 | $109.50M derived: sum of 3 quarters · filed 2019-02-06 | $154.80M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $33.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $72.50M derived: sum of 2 quarters · filed 2017-10-24 | $117.80M 10-Q · filed 2017-10-24 | $147.70M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $38.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $84.10M 10-Q · filed 2017-07-25 | $114.00M derived: sum of 3 quarters · filed 2018-02-01 | $151.80M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $45.30M 10-Q · filed 2017-04-25 | $75.20M derived: sum of 2 quarters · filed 2018-02-01 | $113.00M derived: sum of 3 quarters · filed 2018-02-01 | $154.60M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $29.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $67.70M derived: sum of 2 quarters · filed 2018-02-01 | $109.30M derived: sum of 3 quarters · filed 2018-02-01 | $161.40M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $37.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $79.40M derived: sum of 2 quarters · filed 2016-10-26 | $131.50M 10-Q · filed 2016-10-26 | $131.54M 10-Q · filed 2015-10-21 | $167.29M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $41.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $93.70M 10-Q · filed 2016-07-21 | $93.68M 10-Q · filed 2015-07-24 | $129.49M derived: sum of 3 quarters · filed 2017-02-02 | $165.14M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $52.10M 10-Q · filed 2016-04-21 | $52.06M 10-Q · filed 2015-04-24 | $87.89M derived: sum of 2 quarters · filed 2017-02-02 | $123.54M derived: sum of 3 quarters · filed 2017-02-02 | $161.06M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $35.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $71.44M derived: sum of 2 quarters · filed 2017-02-02 | $108.96M derived: sum of 3 quarters · filed 2017-02-02 | $155.30M 10-K · filed 2017-02-02 | $155.30M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $35.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $73.17M derived: sum of 2 quarters · filed 2015-10-21 | $119.51M 10-Q · filed 2015-10-21 | $150.96M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $37.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $83.86M 10-Q · filed 2015-07-24 | $115.31M derived: sum of 3 quarters · filed 2016-02-03 | $152.77M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $46.34M 10-Q · filed 2015-04-24 | $77.79M derived: sum of 2 quarters · filed 2016-02-03 | $115.25M derived: sum of 3 quarters · filed 2016-02-03 | $145.88M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $31.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $68.91M derived: sum of 2 quarters · filed 2016-02-03 | $99.54M derived: sum of 3 quarters · filed 2016-02-03 | $136.30M 10-K · filed 2016-02-03 | $136.29M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $37.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $68.09M derived: sum of 2 quarters · filed 2014-10-22 | $104.85M 10-Q · filed 2014-10-22 | $135.04M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $30.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $67.39M 10-Q · filed 2014-07-23 | $97.58M derived: sum of 3 quarters · filed 2015-02-04 | $125.49M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $36.76M 10-Q · filed 2014-04-23 | $66.94M derived: sum of 2 quarters · filed 2015-02-04 | $94.86M derived: sum of 3 quarters · filed 2015-02-04 | $122.93M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $30.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $58.10M derived: sum of 2 quarters · filed 2015-02-04 | $86.17M derived: sum of 3 quarters · filed 2015-02-04 | $118.57M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $27.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $55.98M derived: sum of 2 quarters · filed 2013-10-28 | $88.38M 10-Q · filed 2013-10-28 | $114.76M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $28.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $60.47M 10-Q · filed 2013-07-25 | $86.85M derived: sum of 3 quarters · filed 2014-02-06 | $116.07M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $32.40M 10-Q · filed 2013-04-25 | $58.78M derived: sum of 2 quarters · filed 2014-02-06 | $88.00M derived: sum of 3 quarters · filed 2014-02-06 | $112.28M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $26.38M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $55.61M derived: sum of 2 quarters · filed 2014-02-06 | $79.89M derived: sum of 3 quarters · filed 2014-02-06 | $113.00M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $29.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $53.51M derived: sum of 2 quarters · filed 2012-10-25 | $86.63M 10-Q · filed 2012-10-25 | $119.86M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $24.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $57.40M 10-Q · filed 2012-07-24 | $90.63M derived: sum of 3 quarters · filed 2013-02-05 | $129.85M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $33.12M 10-Q · filed 2012-05-01 | $66.35M derived: sum of 2 quarters · filed 2013-02-05 | $105.58M derived: sum of 3 quarters · filed 2013-02-05 | $149.94M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $33.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $72.46M derived: sum of 2 quarters · filed 2013-02-05 | $116.82M derived: sum of 3 quarters · filed 2013-02-05 | $167.83M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $39.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $83.59M derived: sum of 2 quarters · filed 2011-10-28 | $134.59M 10-Q · filed 2011-10-28 | $175.59M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $44.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $95.37M 10-Q · filed 2011-07-26 | $136.37M derived: sum of 3 quarters · filed 2012-02-03 | $177.38M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $51.01M 10-Q · filed 2011-04-21 | $92.01M derived: sum of 2 quarters · filed 2012-02-03 | $133.02M derived: sum of 3 quarters · filed 2012-02-03 | $174.02M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $82.01M derived: sum of 2 quarters · filed 2012-02-03 | $123.01M derived: sum of 3 quarters · filed 2012-02-03 | $160.90M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $41.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $82.01M derived: sum of 2 quarters · filed 2010-10-26 | $119.90M 10-Q · filed 2010-10-26 | $161.77M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | $41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | $78.89M 10-Q · filed 2010-07-20 | $120.76M derived: sum of 3 quarters · filed 2011-02-04 | $157.45M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | $37.89M 10-Q · filed 2010-04-20 | $79.76M derived: sum of 2 quarters · filed 2011-02-04 | $116.45M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | $41.87M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $78.56M derived: sum of 2 quarters · filed 2011-02-04 | $146.21M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | $36.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $104.34M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | $67.65M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | $123.13M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |